Patent intelligence · US
US 11185564
Compositions and methods for the treatment of wounds, disorders, and diseases of the skin
Compositions and methods for the treatment of wounds, disorders, and diseases of the skin
Patent details — US 11185564
- Jurisdiction
- US
- Status
- granted
- Grant date
- Nov 30, 2021
- Expiration
- Nov 25, 2041
- Applicant
- Krystal Biotech, Inc.
- Claims
- 20
- CPC classes
- A61K, A61K35/763, A61K38/1748, A61K38/39
Quick answer
US 11185564 (Compositions and methods for the treatment of wounds, disorders, and diseases of the skin) is held by Krystal Biotech, Inc.. Status: granted. Granted Nov 30, 2021. Expires Nov 25, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Krystal Biotech, Inc.
- Grant date
- Expiration
- Claims
- 20
- CPC classes
- A61K, A61K35/763, A61K38/1748, A61K38/39, A61K47/38, A61K48/005
More from Krystal Biotech, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12364775
Viral vectors for cancer therapy
granted -
US 12128122
Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic
granted -
US 11918660
Viral vectors for cancer therapy
granted -
US 11865148
Methods of delivering transgenes to the eye
granted -
US 11779660
Viral vectors for cancer therapy
granted -
US 11717547
Compositions and methods for the treatment of autosomal recessive congenital ichthyosis
granted -
US 11642384
Compositions and methods for the treatment of Netherton Syndrome
granted
Frequently asked questions
What is US patent 11185564?
US 11185564 (Compositions and methods for the treatment of wounds, disorders, and diseases of the skin) is held by Krystal Biotech, Inc.. Status: granted. Granted Nov 30, 2021. Expires Nov 25, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11185564?
Krystal Biotech, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 14 pharmaceutical patents for this assignee.
When does US 11185564 expire?
Our index shows an expiration date of Nov 25, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.